Innovative stem cell therapy offers hope for restoring muscle strength in rare, inherited muscle disorders
A consortium led by scientists from Maastricht UMC+ is starting clinical trials for an innovative stem cell therapy against genetic muscle disorders and muscle wasting in the elderly, among others. On July 13 and 28, the first two patients with a hereditary muscle disorder of the energy metabolism will receive healthy muscle stem cells from the body. It is the first ever trial worldwide using such stem cells for systemic induction of muscle mass. This offers hope for countless patients in the search for a treatment for hereditary and often very rare diseases.
Under the name Generate Your Muscle (GYM), the researchers want to promote the creation of muscle mass and tissue by using healthy, body-own muscle stem cells. According to the scientists, the use of the body's own muscle stem cells has the great advantage of avoiding the necessary risks associated with the transplantation of donor cells. The uniqueness of the trial is further that although the patients have an inherited muscle disorder of energy metabolism, their muscle stem cells have virtually no hereditary defect. These stem cells can therefore be used directly as therapy. The clinical trial must demonstrate the safety of the treatment and will provide an initial picture of the effectiveness of the procedure.
Also read
-
In a world-record attempt, Golnaz Atefi is taking her interdisciplinary research into Alzheimer’s and dementia care onto the road: 1000km on roller-skates to talk to people with dementia, their families, researchers and care professionals. All to raise awareness about the importance of inclusivity and make sure new technological solutions benefit as many people as possible.
-
How will we feed the world in 2050 in a sustainable and healthy way? Which techniques will we use for this? Maastricht University will start looking for answers on October 8th in a new, environmentally friendly greenhouse on the Brightlands Campus Greenport Venlo.
-
Led by our researcher and geneticist Masoud Zamani Esteki, researchers at Maastricht UMC+ and GROW developed a technique that can analyze the entire genome – all genes and chromosomes – in a single test. This allows a faster and better determination of which embryos are suitable for a successful pregnancy. This research project has been published in Nature Communications this week. Watch this video to find out how there's now a bridge between two seemingly different fields, as well as a new form of PGT has been coined thanks to this research. Visit Zamani Lab for more information.